Public Employees Retirement System of Ohio Acquires New Holdings in Revvity Inc. $RVTY

Public Employees Retirement System of Ohio bought a new stake in Revvity Inc. (NYSE:RVTY) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 34,562 shares of the company’s stock, valued at approximately $3,845,000.

Several other hedge funds also recently bought and sold shares of the stock. Jupiter Topco LLC purchased a new stake in shares of Revvity in the 2nd quarter valued at approximately $961,017,000. BlackRock Inc. purchased a new position in Revvity in the 2nd quarter valued at approximately $852,070,000. Primecap Management Co. CA purchased a new stake in shares of Revvity during the second quarter worth $94,921,000. Norges Bank purchased a new stake in shares of Revvity during the fourth quarter worth $80,382,000. Finally, Bank of America Corp DE acquired a new stake in shares of Revvity in the second quarter valued at $87,116,000. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Revvity Stock Down 0.1%

RVTY opened at $130.77 on Friday. The stock has a market capitalization of $14.59 billion, a P/E ratio of 62.27, a price-to-earnings-growth ratio of 2.38 and a beta of 1.09. Revvity Inc. has a one year low of $81.22 and a one year high of $133.00. The business’s 50-day simple moving average is $116.07 and its 200-day simple moving average is $102.05. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.50 and a current ratio of 1.80.

Revvity (NYSE:RVTY) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $1.41 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.20. The business had revenue of $729.69 million during the quarter, compared to the consensus estimate of $702.96 million. Revvity had a return on equity of 8.34% and a net margin of 8.16%.The company’s revenue was down 1.3% compared to the same quarter last year. During the same period in the prior year, the company earned $1.18 earnings per share. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. Analysts anticipate that Revvity Inc. will post 5.36 EPS for the current year.

Revvity Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Friday, October 23rd will be paid a dividend of $0.07 per share. The ex-dividend date is Friday, October 23rd. This represents a $0.28 annualized dividend and a dividend yield of 0.2%. Revvity’s dividend payout ratio is 13.33%.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the company. Weiss Ratings raised Revvity from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, July 30th. Zacks Research raised Revvity from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 4th. Wall Street Zen cut shares of Revvity from a “buy” rating to a “hold” rating in a report on Sunday, August 16th. TD Cowen reiterated a “buy” rating on shares of Revvity in a research note on Wednesday, July 15th. Finally, Royal Bank Of Canada assumed coverage on shares of Revvity in a report on Tuesday. They set a “sector perform” rating and a $135.00 price target for the company. Three research analysts have rated the stock with a Buy rating and thirteen have issued a Hold rating to the company. Based on data from MarketBeat.com, Revvity currently has a consensus rating of “Hold” and an average price target of $110.58.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.